Company Overview
Snapshot
Founded in October 2014 by Nadav Eyal, Eybna Technologies operates with 51–200 employees. The company is a technology firm and terpene manufacturer, focusing on utilizing cannabis phytochemicals for therapeutic benefits. In November 2021, Eybna established a cooperation with Gat Foods (IBBL), part of the CBC group, to develop a new category of functional beverages.
Business overview
Eybna Technologies is a technology company specializing in the manufacturing of terpenes, with an R&D center dedicated to exploring the therapeutic benefits of cannabis phytochemicals. The company integrates advanced research through academic and industry partnerships to develop easily applicable products. Eybna serves the Health Tech & Life Sciences sector, operating within the Pharmaceuticals, Biotechnology, and Medical Cannabis industries, with a focus on wellness, food and beverages, and cannabis markets.
Strategic signal
In November 2021, Eybna Technologies established a strategic cooperation with Gat Foods (IBBL), a division of Israel's largest beverage company, CBC group. This partnership is aimed at developing a new category of functional beverages, signaling Eybna's expansion beyond its core terpene manufacturing into consumer-facing product development and validating the commercial potential of its research in the food and beverage industry.
Company Intelligence Q&A
- What is Eybna Technologies' primary focus?
- Eybna Technologies is a technology company and terpene manufacturer, with an R&D center focused on utilizing the therapeutic benefits of cannabis phytochemicals, particularly terpenes, for health applications.
- When was Eybna Technologies founded?
- Eybna Technologies was founded in October 2014.
- Who is a co-founder of Eybna Technologies?
- Nadav Eyal is a co-founder and CEO of Eybna Technologies.
- What was a key partnership for Eybna Technologies in 2021?
- In November 2021, Eybna Technologies established a cooperation with Gat Foods (IBBL), part of the CBC group, to develop a new category of functional beverages.
- What research did Eybna Technologies conduct regarding viral infections?
- In April 2020, Eybna Technologies joined forces with CannaSoul to prove a proprietary terpene formulation for treating viral infections by modulating cytokine storm.